News

Athens, Ohio-based Diagnostic Hybrids, is a manufacturer of direct fluorescent in vitro diagnostic assays used in hospital and reference laboratories for a variety of diseases, including viral respiratory

Epeius claimed that the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century, in accordance with an FDA Critical Path

Genoptix has obtained exclusive commercial laboratory rights in the US to develop and perform three solid tumor assays using HistoRx’s proprietary technology for analysis of fluorescent immunohistochemistry (fIHC),

MIT currently produces the 1000 Rapid Microbial Identification (ID) System that can identify bacteria in less than five minutes with a laser that uses the principles of light

The study has demonstrated that VRX1023 is capable of achieving control of viral load over the course of four months following a challenge with a pathogenic simian immunodeficiency

Zyto’s SMP program teams Zyto with nutriceutical suppliers who serve healthcare professionals exclusively. Vaughn Cook, CEO of Zyto, said: “The SMP program is a joint effort between Zyto

Earlier, in October 2009, the division of reproductive and urologic products at FDA has issued a complete response letter for the biologic license application (BLA) for Prolia in

The instrument removes a key bottleneck in the current workflow for sequencing by replacing the tedious gel isolation and purification steps used for size selection of sheared genomic

The Acquisition was finalised after the approval by Asterand’s shareholders at an extraordinary general meeting held on February 18, 2010, where all resolutions put to shareholders were duly